Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot M Frohman

Showing results (41-50 of 181) with videos related to

Pageof 19
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2011
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegenerationKristin M Galetta, Peter A Calabresi, Elliot M Frohman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 31, 2010
Thermoregulation in multiple sclerosisScott L Davis, Thad E Wilson, Andrea T White, et al.
Current Opinion in Neurology|April 23, 2014
An update on neuro-ophthalmology of multiple sclerosis: the visual system as a model to study multiple sclerosisSara S Qureshi, Shin C Beh, Teresa C Frohman, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 14, 2018
New Ways of "Seeing" the Mechanistic Heterogeneity of Multiple Sclerosis Plaque PathogenesisEthan I Meltzer, Fiona E Costello, Elliot M Frohman, et al.
Journal of Neuroimmunology|February 10, 2016
B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responsesSara J Ireland, Alyssa A Guzman, Elliot M Frohman, et al.
Expert Review of Clinical Immunology|October 17, 2013
Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'Eugene O Major, Daniel C Douek, Elliot M Frohman, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2012
From injection therapies to natalizumab: views on the treatment of multiple sclerosisRoberto Bomprezzi, Darin T Okuda, Yazan J Alderazi, et al.
Brain Communications|November 25, 2024
The bidirectional brain-cochlea axis: a scaffold for neurologic disease-associated hearing lossArianna Di Stadio, Elliot M Frohman, Daniela Messineo, et al.
The Lancet. Neurology|January 25, 2005
The neuro-ophthalmology of multiple sclerosisElliot M Frohman, Teresa C Frohman, David S Zee, et al.
Urology|April 26, 2006
Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosisGary E Lemack, Elliot M Frohman, Philippe E Zimmern, et al.
Pageof 19

Showing results (41-50 of 181) with videos related to

Sort By:
Pageof 19
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 29, 2011
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegenerationKristin M Galetta, Peter A Calabresi, Elliot M Frohman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 31, 2010
Thermoregulation in multiple sclerosisScott L Davis, Thad E Wilson, Andrea T White, et al.
Current Opinion in Neurology|April 23, 2014
An update on neuro-ophthalmology of multiple sclerosis: the visual system as a model to study multiple sclerosisSara S Qureshi, Shin C Beh, Teresa C Frohman, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|February 14, 2018
New Ways of "Seeing" the Mechanistic Heterogeneity of Multiple Sclerosis Plaque PathogenesisEthan I Meltzer, Fiona E Costello, Elliot M Frohman, et al.
Journal of Neuroimmunology|February 10, 2016
B cells from relapsing remitting multiple sclerosis patients support neuro-antigen-specific Th17 responsesSara J Ireland, Alyssa A Guzman, Elliot M Frohman, et al.
Expert Review of Clinical Immunology|October 17, 2013
Two demyelinating diseases in the brain of a single patient, PML and MS: how to minimize 'one' while treating the 'other'Eugene O Major, Daniel C Douek, Elliot M Frohman, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2012
From injection therapies to natalizumab: views on the treatment of multiple sclerosisRoberto Bomprezzi, Darin T Okuda, Yazan J Alderazi, et al.
Brain Communications|November 25, 2024
The bidirectional brain-cochlea axis: a scaffold for neurologic disease-associated hearing lossArianna Di Stadio, Elliot M Frohman, Daniela Messineo, et al.
The Lancet. Neurology|January 25, 2005
The neuro-ophthalmology of multiple sclerosisElliot M Frohman, Teresa C Frohman, David S Zee, et al.
Urology|April 26, 2006
Urodynamic distinctions between idiopathic detrusor overactivity and detrusor overactivity secondary to multiple sclerosisGary E Lemack, Elliot M Frohman, Philippe E Zimmern, et al.
Pageof 19